Immunome (IMNM)
NASDAQ:IMNM
US Market
Holding IMNM?
Track your performance easily

Immunome (IMNM) Technical Analysis

194 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
4Neutral
8Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Immunome’s (IMNM) Moving Averages Convergence Divergence (MACD) indicator is -0.06, suggesting Immunome is a Sell.
Immunome’s (IMNM) 20-Day exponential moving average is 12.60, while Immunome’s (IMNM) share price is $12.5, making it a Buy.
Immunome’s (IMNM) 50-Day exponential moving average is 13.08, while Immunome’s (IMNM) share price is $12.5, making it a Buy.

Immunome (IMNM) Pivot Points

Nov 12, 2024, 04:30 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
11.88
12.29
12.64
13.05
13.40
13.81
14.16
Fibonacci
12.29
12.58
12.76
13.05
13.34
13.52
13.81
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Immunome (IMNM) Moving Averages

Nov 12, 2024, 04:30 PM
Period
Simple
Exponential
MA5
12.97Buy
12.91Buy
MA10
12.51Buy
12.67Buy
MA20
12.29Buy
12.60Buy
MA50
13.35Sell
13.08Buy
MA100
13.55Sell
13.63Sell
MA200
16.32Sell
14.60Sell
Immunome’s (IMNM) 10-Day exponential moving average is 12.67, while Immunome’s (IMNM) share price is $12.5, making it a Buy.
Immunome’s (IMNM) 100-Day exponential moving average is 13.63, while Immunome’s (IMNM) share price is $12.5, making it a Sell.
Immunome’s (IMNM) stock price is $12.5 and Immunome’s (IMNM) 50-day simple moving average is 13.35, creating a Sell signal.
Immunome’s (IMNM) stock price is $12.5 and Immunome’s (IMNM) 100-day simple moving average is 13.55, creating a Sell signal.
Immunome’s (IMNM) stock price is $12.5 and Immunome’s (IMNM) 200-day simple moving average is 16.32, creating a Sell signal.

Immunome (IMNM) Technical Indicators

Nov 12, 2024, 04:30 PM
Name
Value
Implied Action
RSI (14)
56.16
Neutral
STOCH (9,6)
67.55
Neutral
STOCHRSI (14)
68.53
Neutral
MACD (12,26)
-0.06
Sell
ADX (14)
14.58
Buy
Williams %R
-17.17
Sell
CCI (14)
147.36
Sell
ATR (14)
0.75
-
Ultimate Oscillator
51.17
Neutral
ROC
13.24
Buy
Immunome’s (IMNM) Relative Strength Index (RSI) is 56.16, creating a Neutral signal.
Immunome’s (IMNM) Trend Strength Indicator (ADX) is 14.58, creating a Buy signal.
Immunome’s (IMNM) Commodity Channel Index (CCI) is 147.36, creating a Sell signal.
Immunome’s (IMNM) Price Rate of Change (ROC) is 13.24, creating a Buy signal.

FAQ

Is IMNM a Buy, Hold, or Sell?
Based on IMNM’s technical indicators, IMNM is a Hold.
    What is IMNM’s RSI (14)?
    IMNM’s RSI (14) is 56.16, which suggests IMNM is a Neutral.
      What is IMNM’s MACD?
      IMNM’s MACD is -0.06, which suggests IMNM is a Sell.
        What is IMNM’s 5-day moving average?
        IMNM’s 5-day moving average is 12.97, which suggests IMNM is a Buy.
          What is IMNM’s 20-day moving average?
          IMNM 20-day moving average is 12.29, which suggests IMNM is a Buy.
            What is IMNM’s 50-day moving average?
            IMNM’s 50-day moving average is 13.35, which suggests IMNM is a Sell.
              What is IMNM’s 200-day moving average?
              IMNM’s 200-day moving average is 16.32, which suggests IMNM is a Sell.
                What is IMNM’s Williams % R (14)?
                IMNM’s Williams % R (14) is -17.17, which suggests IMNM is a Sell.
                  What is IMNM’s CCI (14)?
                  IMNM’s CCI (14) is 147.36, which suggests IMNM is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis